Online ISSN: 2515-8260

Keywords : scale GMFCS


IMPROVING THE TACTICS OF TREATING CHILDREN WITH SEVERE CEREBRAL PALSY

Zilola Mavlyanova; Gulnoza Burkhanova; Maftuna Ravshanova; Sardor Makhmudov; Sanzhar Kholboyev

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 2, Pages 1623-1631

This article discusses severe forms of cerebral palsy in children of different ages
and the development of anemia in these children, and iron supplements are needed to treat
such children (III). The lack of data on this disease and the effect of ferric iron
preparations on the course and prognosis of infantile cerebral palsy served as the
relevance of the study.
The aim of the study. To evaluate the effectiveness of the use of ferric iron (Emfer)
preparations on the course and prognosis of infantile cerebral palsy.
Materials and research methods. To achieve this goal, the results of treatment of 67 sick
children with severe cerebral palsy were analyzed. Children age from 2 to 17 years old. All
patients were ranked by age groups in accordance with the age classification with the
GMFCS scale: up to 2 years old - 9 children (13.43%), 2-3 years old - 11 children (16.4%),
4-6 years old - 18 children (26.8%), 7-12 years old - 15 children (22.38%), 13-17 years old -
14 children (20.9%). The study group was divided into 3 subgroups of motor deficit
according to the GMFCS scale: level 3 - 16 children (23.88%), level 4 - 20 children
(29.85%), level 5 - 31 children (46.27%). All patients were divided into 2 groups - the main
group - 38 children (56.71%, age - 11.04 ± 6.3 years), for whom anemia was corrected
using the Emfer preparation based on ferric iron, and the comparison group - 29 children
(43.29%, age - 12.06 ± 5.1 years), who were treated without iron supplements.